NeuroFore
PrivateLast Round
Grant
Apr 15, 2026
Total Funding Raised
$37,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroFore is a biotechnology company that is developing a revolutionary AI-based diagnostic application for the early diagnosis of Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroFore Comparables
Compare NeuroFore with similar companies based on industry and business-model similarity.
NeuroFore Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Grant | Nov 19, 2025 |
NeuroFore Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship | Grant |
| Sling Health STL | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
$25K grant from Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship.
- Nov 19, 2025
$10K grant received from Skandalaris Center.
NeuroFore Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeuroFore's valuation, stock price, and market status.
Is NeuroFore a public or private company?
NeuroFore is a private company.
What is the current stock price of NeuroFore?
NeuroFore is a private company with no public stock price. No recent secondary market data is available.
How much is NeuroFore worth (valuation)?
Valuation information for NeuroFore is not publicly available.
Can I buy NeuroFore stock?
NeuroFore shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeuroFore's last funding round?
NeuroFore's most recent funding round was Grant on April 15, 2026.
Who are the main investors in NeuroFore?
Key investors in NeuroFore include Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship, Sling Health STL.
Will NeuroFore IPO soon?
No public IPO plans have been announced for NeuroFore.
How can I track NeuroFore secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeuroFore's secondary market activity and sign up for updates.